410 related articles for article (PubMed ID: 30552137)
1. Influenza virus N-linked glycosylation and innate immunity.
York IA; Stevens J; Alymova IV
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30552137
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Cellular Glycosylation May Increase the Ability of Influenza Viruses to Escape Host Immune Responses through Modification of the Viral Glycome.
Alymova IV; Cipollo JF; Parsons LM; Music N; Kamal RP; Tzeng WP; Goldsmith CS; Contessa JN; Hartshorn KL; Wilson JR; Zeng H; Gansebom S; York IA
mBio; 2022 Apr; 13(2):e0298321. PubMed ID: 35285699
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation of the Hemagglutinin Protein of H5N1 Influenza Virus Increases Its Virulence in Mice by Exacerbating the Host Immune Response.
Zhao D; Liang L; Wang S; Nakao T; Li Y; Liu L; Guan Y; Fukuyama S; Bu Z; Kawaoka Y; Chen H
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100622
[TBL] [Abstract][Full Text] [Related]
4. Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.
Cao P; Yan AW; Heffernan JM; Petrie S; Moss RG; Carolan LA; Guarnaccia TA; Kelso A; Barr IG; McVernon J; Laurie KL; McCaw JM
PLoS Comput Biol; 2015 Aug; 11(8):e1004334. PubMed ID: 26284917
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation of Hemagglutinin and Neuraminidase of Influenza A Virus as Signature for Ecological Spillover and Adaptation among Influenza Reservoirs.
Kim P; Jang YH; Kwon SB; Lee CM; Han G; Seong BL
Viruses; 2018 Apr; 10(4):. PubMed ID: 29642453
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.
Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
Viruses; 2018 Dec; 10(12):. PubMed ID: 30545063
[TBL] [Abstract][Full Text] [Related]
9. Development of next generation hemagglutinin-based broadly protective influenza virus vaccines.
Nachbagauer R; Palese P
Curr Opin Immunol; 2018 Aug; 53():51-57. PubMed ID: 29680576
[TBL] [Abstract][Full Text] [Related]
10. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
Pushko P; Pearce MB; Ahmad A; Tretyakova I; Smith G; Belser JA; Tumpey TM
Vaccine; 2011 Aug; 29(35):5911-8. PubMed ID: 21723354
[TBL] [Abstract][Full Text] [Related]
11. Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection.
Tate MD; Job ER; Deng YM; Gunalan V; Maurer-Stroh S; Reading PC
Viruses; 2014 Mar; 6(3):1294-316. PubMed ID: 24638204
[TBL] [Abstract][Full Text] [Related]
12. Innate and adaptive T cells in influenza disease.
Nüssing S; Sant S; Koutsakos M; Subbarao K; Nguyen THO; Kedzierska K
Front Med; 2018 Feb; 12(1):34-47. PubMed ID: 29352371
[TBL] [Abstract][Full Text] [Related]
13. Influenza Virus-Host Co-evolution. A Predator-Prey Relationship?
Voskarides K; Christaki E; Nikolopoulos GK
Front Immunol; 2018; 9():2017. PubMed ID: 30245689
[TBL] [Abstract][Full Text] [Related]
14. Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies.
Job ER; Deng YM; Tate MD; Bottazzi B; Crouch EC; Dean MM; Mantovani A; Brooks AG; Reading PC
J Immunol; 2010 Oct; 185(7):4284-91. PubMed ID: 20817882
[TBL] [Abstract][Full Text] [Related]
15. Influenza vaccines: 'tailor-made' or 'one fits all'.
Saletti G; Gerlach T; Rimmelzwaan GF
Curr Opin Immunol; 2018 Aug; 53():102-110. PubMed ID: 29734023
[TBL] [Abstract][Full Text] [Related]
16. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
17. Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches.
Sabbaghi A; Miri SM; Keshavarz M; Mahooti M; Zebardast A; Ghaemi A
Virol J; 2020 Nov; 17(1):174. PubMed ID: 33183352
[TBL] [Abstract][Full Text] [Related]
18. Contribution of innate immune cells to pathogenesis of severe influenza virus infection.
Cole SL; Ho LP
Clin Sci (Lond); 2017 Feb; 131(4):269-283. PubMed ID: 28108632
[TBL] [Abstract][Full Text] [Related]
19. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
[TBL] [Abstract][Full Text] [Related]
20. Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.
Nogales A; Rodriguez L; DeDiego ML; Topham DJ; Martínez-Sobrido L
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
